296 related articles for article (PubMed ID: 7742788)
1. Effect of a combination of ecabet sodium and cimetidine on experimentally induced gastric lesions and gastric mucosal resistance to ulcerogenic agents in rats.
Kinoshita M; Noto T; Tamaki H
Biol Pharm Bull; 1995 Feb; 18(2):223-6. PubMed ID: 7742788
[TBL] [Abstract][Full Text] [Related]
2. Effects of the anti-ulcer agents ecabet sodium, cimetidine and sucralfate on acetylsalicylic acid-induced gastric mucosal damage deteriorated by renal failure in rats.
Nogi K; Taniguchi H; Onoda Y
Arzneimittelforschung; 2002; 52(11):828-32. PubMed ID: 12489254
[TBL] [Abstract][Full Text] [Related]
3. Possible mechanism of increase in gastric mucosal PGE2 and PGI2 generation induced by ecabet sodium, a novel gastroprotective agent.
Kinoshita M; Tamaki H
Dig Dis Sci; 1997 Jan; 42(1):83-90. PubMed ID: 9009120
[TBL] [Abstract][Full Text] [Related]
4. Effects of ecabet sodium (TA-2711), a new antiulcer agent, on gastrointestinal mucosal prostanoid production and morphology in rats.
Kinoshita M; Iwasaki H; Yasoshima A; Tamaki H
Biol Pharm Bull; 1993 Dec; 16(12):1220-5. PubMed ID: 8130770
[TBL] [Abstract][Full Text] [Related]
5. Roles of prostaglandins, nitric oxide and the capsaicin-sensitive sensory nerves in gastroprotection produced by ecabet sodium.
Kinoshita M; Kume E; Tamaki H
J Pharmacol Exp Ther; 1995 Oct; 275(1):494-501. PubMed ID: 7562591
[TBL] [Abstract][Full Text] [Related]
6. Relationship between gastroprotective effect of locally acting antiulcer agent ecabet sodium and its binding to gastric mucosa in rats. Comparison with sucralfate.
Kinoshita M; Yamasaki K; Kokusenya Y; Tamaki H
Dig Dis Sci; 1995 Mar; 40(3):661-7. PubMed ID: 7895562
[TBL] [Abstract][Full Text] [Related]
7. Effects of 12-sulfodehydroabietic acid monosodium salt (TA-2711), a new anti-ulcer agent, on gastric secretion and experimental ulcers in rats.
Onoda Y; Magaribuchi T; Tamaki H
Jpn J Pharmacol; 1989 Sep; 51(1):65-73. PubMed ID: 2509775
[TBL] [Abstract][Full Text] [Related]
8. Effects of sucralfate, cimetidine and rabeprazole on mucosal hydroxyproline content in healing of ethanol-hcl-induced gastric lesions.
Arisawa T; Shibata T; Kamiya Y; Nagasaka M; Nakamura M; Fujita H; Hasegawa S; Harata M; Nakamura M; Mizuno T; Tahara T; Ohta Y; Nakano H
Clin Exp Pharmacol Physiol; 2006 Jul; 33(7):628-32. PubMed ID: 16789931
[TBL] [Abstract][Full Text] [Related]
9. Combination therapy of ecabet sodium and cimetidine compared with cimetidine alone for gastric ulcer: prospective randomized multicenter study.
Murata H; Kawano S; Tsuji S; Kamada T; Matsuzawa Y; Katsu K; Inoue K; Kobayashi K; Mitsufuji S; Bamba T; Kawasaki H; Kajiyama G; Umegaki E; Inoue M; Saito I
J Gastroenterol Hepatol; 2003 Sep; 18(9):1029-33. PubMed ID: 12911658
[TBL] [Abstract][Full Text] [Related]
10. Effects of the new anti-ulcer agent KB-5492 on experimental gastric mucosal lesions and gastric mucosal defensive factors, as compared to those of teprenone and cimetidine.
Morimoto Y; Shimohara K; Oshima S; Sukamoto T
Jpn J Pharmacol; 1991 Dec; 57(4):495-505. PubMed ID: 1803065
[TBL] [Abstract][Full Text] [Related]
11. Effects of ecabet sodium, a novel gastroprotective agent, on mucin metabolism in rat gastric mucosa.
Ichikawa T; Ishihara K; Hayashida H; Hiruma H; Saigenji K; Hotta K
Dig Dis Sci; 2000 Mar; 45(3):606-13. PubMed ID: 10749340
[TBL] [Abstract][Full Text] [Related]
12. Effect of DS-4574, a novel peptidoleukotriene antagonist with mast cell stabilizing action, on acute gastric lesions and gastric secretion in rats.
Tabuchi Y; Kurebayashi Y
Jpn J Pharmacol; 1992 Dec; 60(4):335-40. PubMed ID: 1287268
[TBL] [Abstract][Full Text] [Related]
13. Effects of KW-5805, a new antiulcer agent, on experimental gastric and duodenal ulcers, gastric mucosal lesions by necrotizing agents and gastric acid secretion.
Kosaka N; Tanaka H; Tomaru A; Ishii A; Shuto K
Jpn J Pharmacol; 1994 Aug; 65(4):305-12. PubMed ID: 7990267
[TBL] [Abstract][Full Text] [Related]
14. Effects of MCI-727, a new antiulcer agent, on various gastric and duodenal lesions in experimental animals.
Yamazaki S; Kawamura M; Kitsukawa M; Ando K; Nitta I; Tobe A; Okabe S
Jpn J Pharmacol; 1991 Apr; 55(4):415-24. PubMed ID: 1886287
[TBL] [Abstract][Full Text] [Related]
15. Effects of anti-ulcer agents on ethanol-induced gastric mucosal lesions in D-galactosamine-induced hepatitis rats.
Taniguchi H; Yomota E; Nogi K; Onoda Y
Arzneimittelforschung; 2002; 52(8):600-4. PubMed ID: 12236047
[TBL] [Abstract][Full Text] [Related]
16. Ecabet sodium, a novel locally-acting anti-ulcer agent, protects the integrity of the gastric mucosal gel layer from pepsin-induced disruption in the rat.
Kinoshita M; Endo M; Yasoshima A; Saito N; Yamasaki K; Chishima S; Narita H
Aliment Pharmacol Ther; 1999 May; 13(5):687-94. PubMed ID: 10233194
[TBL] [Abstract][Full Text] [Related]
17. Studies on antiulcer agents. IV. Antiulcer effects of 2-benzylthio5,6,7,8-tetrahydro-4(3H)-quinazolinones and related compounds.
Terashima K; Shimamura H; Kawase A; Tanaka Y; Tanimura T; Kamisaki T; Ishizuka Y; Sato M
Chem Pharm Bull (Tokyo); 1995 Nov; 43(11):2021-3. PubMed ID: 8575039
[TBL] [Abstract][Full Text] [Related]
18. Effects of 12-sulfodehydroabietic acid monosodium salt (TA-2711), a new anti-ulcer agent, on gastric mucosal lesions induced by necrotizing agents and gastric mucosal defensive factors in rats.
Onoda Y; Takido M; Magaribuchi T; Tamaki H
Jpn J Pharmacol; 1990 Apr; 52(4):631-8. PubMed ID: 2342230
[TBL] [Abstract][Full Text] [Related]
19. Ecabet sodium prevents esophageal lesions induced by the reflux of gastric juice in rats.
Okuyama K; Saito N; Kume E; Noto T; Nagasaki M
Inflammopharmacology; 2007 Apr; 15(2):90-4. PubMed ID: 17450449
[TBL] [Abstract][Full Text] [Related]
20. Effect of ecabet disodium, a novel locally-acting antiulcer drug, on epithelial restitution following injury by hypertonic NaCl in bullfrog stomach in vitro.
Furukawa O; Kume E; Sugamoto S; Kawauchi S; Takeuchi K
Digestion; 2000; 62(2-3):116-25. PubMed ID: 11025359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
